CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 330

Industry reads hand-picked by our editors

Aug 24, 2016

Forbes
Life after Martin Shkreli—A conversation with Turing Pharmaceutical's R&D head
MIT Technology Review
35 innovators under 35
Stat
Experimental cancer therapy holds great promise—but at great cost
Xconomy
In wake of infamous biotech party, 20 women join new exec training

Aug 23, 2016

pharma phorum
EU approves Gilead’s Truvada for HIV prevention
STAT
The science of mass hysteria: When we face uncertainty, our minds crave explanations
The Wall Street Journal
With Moderate Drinking Under Fire, Alcohol Companies Go on Offensive

Aug 22, 2016

STAT
26 overdoses in just hours: Inside a community on the front lines of the opioid epidemic
MM&M
Healthcare agencies not immune to gender bias, parity issues
Xconomy
War, Surgery, and Cancer Vaccines: Meet San Antonio’s George Peoples

Aug 19, 2016

Ad Age
McDonald's Pulls Happy Meal Fitness Bands Due to Skin Irritation
In The Pipeline
Three Diseases at Once?
STAT
HIPAA turns 20: Five things you should know about your medical records

Aug 18, 2016

STAT
Do incentives nudge physicians to prescribe opioids for pain?
MM&M
Lobbyists create off-label principles following FDA lawsuits
mobihealthnews
AstraZeneca plans new connected inhaler trial to improve medication adherence in COPD patients

Aug 17, 2016

Forbes
$81 Million in Zika Funding: Winners and Losers
CNBC
Rare biotech buying opportunity, says Morgan Stanley
The New York Times
Osteoporosis, a Disease With Few Treatment Options, May Soon Have One More

Aug 16, 2016

Wall Street Journal
Chance collaboration yields an advance in cancer treatment
BloombergGadfly
Read the Label on Pharma's New Drug Sales
Stat
5 ways drug makers and the health care industry are shaping campaigns
New Yorker
The race for a Zika vaccine

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Trendline
Inside the world of cell therapies Supported by ProBio CDMO
Trendline
Inside the market strategies of today’s drugmakers Supported by Evaluate
Trendline
The latest developments on the gene therapy frontier Supported by Mirus Bio LLC

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce
Revolutionizing Next Generation Gene Therapies with On-Demand Large DNA Construct Synthesis and Novel, Designable Delivery Vehicles Webinar - on demand • Provided by Ansa Biotechnologies
2026 Life Sciences AI & Data Predictions Webinar - on demand • Provided by Snowflake

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.